Regeneron Pharmaceuticals...

685.26
-13.48 (-1.93%)
At close: Mar 03, 2025, 3:59 PM
684.00
-0.18%
After-hours: Mar 03, 2025, 04:09 PM EST

Regeneron Pharmaceuticals Income Statement

Year FY24 FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11 FY10 FY09 FY08 FY07 FY06 FY05 FY04 FY03 FY02 FY01 FY00 FY99 FY98 FY97 FY96 FY95 FY94 FY93 FY92 FY91 FY90
Revenue 14.2B 13.12B 12.17B 16.07B 8.5B 7.86B 6.71B 5.87B 4.86B 4.1B 2.82B 2.1B 1.38B 445.82M 459.07M 379.27M 238.46M 125.02M 63.45M 66.19M 174.02M 57.5M 21.99M 21.97M 59.28M 34.5M 38.2M 33.1M 24.1M 27.4M 23.2M 10.6M 11.5M 7.3M 5M
Cost of Revenue 1.97B 1.82B 1.56B 2.44B 1.12B 782.2M 434.1M 397.06M 299.69M 392.71M 205.02M 155.35M 84.45M 4.22M 2.09M 1.69M 923K n/a 8.15M 9.56M 15.21M 6.68M 6.48M 6.51M 15.57M 3.6M 5M 2.6M 1.1M n/a n/a n/a n/a 12.8M 6.3M
Gross Profit 12.23B 11.3B 10.61B 13.63B 7.38B 7.08B 6.28B 5.48B 4.56B 3.71B 2.61B 1.95B 1.29B 441.61M 456.98M 377.58M 237.53M 125.02M 55.3M 56.64M 158.8M 50.82M 15.51M 15.46M 43.71M 30.9M 33.2M 30.5M 23M 27.4M 23.2M 10.6M 11.5M -5.5M -1.3M
Operating Income 3.99B 4.05B 4.74B 8.95B 3.58B 2.21B 2.53B 2.08B 1.33B 1.25B 838.43M 760.03M 457.71M -205.16M -97.47M -74.1M -89.83M -114.45M -107.66M 124.42M 5.65M -99.99M -121.95M -85.68M -25.28M -23.8M -12.6M -7.5M -17.3M -7.6M -29.2M -38.8M -18.3M -9.6M -3.3M
Interest Income 711.4M 495.9M 160.1M 45.8M 18.5M 30.2M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Pretax Income 4.78B 4.2B 4.86B 9.33B 3.81B 2.43B 2.55B 2.08B 1.33B 1.23B 775.75M 713.36M 414.42M -222.89M -104.47M -71.95M -80.36M -93.56M -91.11M 124.42M 53.87M -95.53M -112.52M -73.52M -29.85M -22.8M -8.2M -7.5M -17.3M -7.6M n/a n/a n/a -4.4M n/a
Net Income 4.41B 3.95B 4.34B 8.08B 3.51B 2.12B 2.44B 1.2B 895.52M 636.06M 348.07M 424.36M 750.27M -221.76M -104.47M -67.83M -82.71M -105.6M -102.34M -95.45M 41.7M -107.46M -124.38M -76.18M -23.21M -23.1M -8.6M -11.6M -32.4M -23.5M -30.7M -39.9M -19.1M -4.5M -3.3M
Selling & General & Admin 2.95B 2.63B 2.12B 1.82B 1.35B 1.83B 1.56B 1.32B 1.18B 838.53M 504.75M 329.42M 210.75M 117.26M 65.2M 52.92M 49.35M 37.87M 25.89M 25.48M 17.06M 14.79M 12.53M 9.61M 8.31M 6.4M 5.8M 5.8M 5.9M 5.8M 8.5M 46.3M 27.8M 3.3M 1.7M
Research & Development 5.13B 4.44B 3.59B 2.91B 2.73B 3.04B 2.19B 2.08B 2.05B 1.62B 1.27B 859.95M 625.55M 529.51M 489.25M 398.76M 278.02M 201.61M 137.06M 155.58M 136.09M 136.02M 124.93M 91.54M 56.26M 44.9M 37M 27.8M 28.3M 23.3M 39.7M n/a n/a n/a n/a
Other Expenses 154.4M n/a -89.9M -45.6M -280.4M 219.3M 19.1M -1.08M -926K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a -248.84M n/a n/a n/a n/a 4.42M 3.4M 3M 4.4M 6.1M 5.9M 4.2M 3.1M 2M 800K 300K
Operating Expenses 8.24B 7.25B 5.62B 4.69B 3.8B 4.87B 3.74B 3.4B 3.23B 2.46B 1.78B 1.19B 836.31M 646.77M 554.45M 451.69M 327.36M 239.48M 162.96M -67.78M 153.16M 150.81M 137.46M 101.15M 68.99M 54.7M 45.8M 38M 40.3M 35M 52.4M 49.4M 29.8M 4.1M 2M
Interest Expense 55.2M 73M 59.4M 57.3M 56.9M 30.2M 28.2M 25.12M 7.2M 14.24M 37.37M 46.44M 45.3M 21.28M 9.12M 2.34M 7.75M 12.04M n/a n/a n/a n/a n/a n/a 4.58M n/a n/a 3.4M 14.3M 14.7M n/a n/a n/a n/a n/a
Selling & Marketing Expenses n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses 10.21B 9.07B 7.18B 7.12B 4.92B 5.65B 4.18B 3.79B 3.53B 2.85B 1.98B 1.34B 920.76M 650.98M 556.55M 453.37M 328.29M 239.48M 171.1M -58.23M 168.37M 157.49M 143.94M 107.66M 84.55M 58.3M 50.8M 40.6M 41.4M 35M 52.4M 49.4M 29.8M 16.9M 8.3M
Income Tax 367.3M 245.7M 520.4M 1.25B 297.2M 313.3M 109.1M 880M 434.29M 589.04M 427.67M 289M -335.85M -1.13M -2.12M -4.12M 2.35M -29.75M -21.87M 178.85M -84.28M 3.01M -7.01M -21.66M 2.51M -1.7M -8.4M 7.5M 29.4M 30.6M 1.5M 1.1M 800K -10.3M n/a
Shares Outstanding (Basic) 107.9M 106.7M 107.1M 105.7M 107.6M 109.2M 114.8M 115.9M 116.25M 115.23M 113.41M 111.22M 111.07M 90.61M 82.93M 79.78M 78.83M 66.33M 57.97M 55.95M 55.42M 50.45M 43.95M 42.09M 35.17M 31.22M 30.71M 29M 24.46M 19.75M 18.95M 16.56M 15.4M 15.52M 15.36M
Shares Outstanding (Diluted) 115.1M 113.7M 113.5M 112.2M 115.1M 114.6M 114.8M 115.91M 116.3M 115.23M 113.47M 111.29M 115.38M 90.61M 82.93M 79.78M 78.83M 66.33M 57.97M 55.95M 56.17M 50.45M 43.95M 42.09M 35.17M 31.45M 31M 29M 24.46M 19.75M 18.95M 16.56M 15.4M 15.52M 15.36M
EPS (Basic) 40.90 37.05 40.51 76.40 32.65 19.38 21.29 11.27 8.55 6.17 3.36 4.23 7.92 -2.45 -1.26 -0.85 -1.05 -1.59 -1.77 -1.71 0.75 -2.13 -2.83 -1.81 -0.66 -0.74 -0.28 -0.4 -1.32 -1.19 -1.62 -2.41 -1.24 -0.29 -0.21
EPS (Diluted) 38.34 34.77 38.22 71.97 30.52 18.46 21.29 10.34 7.70 5.52 2.98 3.72 6.75 -2.45 -1.26 -0.85 -1.05 -1.59 -1.77 -1.71 0.74 -2.13 -2.83 -1.81 -0.66 -0.73 -0.28 -0.4 -1.32 -1.19 -1.62 -2.41 -1.24 -0.29 -0.21
EBITDA 5.32B 4.69B 5.34B 9.28B 3.9B 2.42B 2.68B 2.08B 1.44B 1.33B 876.61M 784.25M 496.67M -170.53M -75.66M -55.37M -61.32M -82.07M -93.06M 139.93M -27.22M -91.51M -113.5M -79.61M -20.86M -20.4M -9.5M -9.3M -11.2M -1.7M -25M -35.7M -16.3M -8.8M -3M
Depreciation & Amortization 482.9M 421M 341.4M 286.2M 235.9M 210.3M 148.2M 145.47M 104.75M 74.91M 52.69M 41.2M 36.94M 31.08M 19.69M 14.25M 11.29M 11.49M 14.59M 15.5M 15.36M 12.94M 8.45M 6.08M 4.42M 3.4M 3M 4.4M 6.1M 5.9M 4.2M 3.1M 2M 800K 300K